129 related articles for article (PubMed ID: 27277477)
21. Overexpression of Cdc20 in clinically localized prostate cancer: Relation to high Gleason score and biochemical recurrence after laparoscopic radical prostatectomy.
Mao Y; Li K; Lu L; Si-Tu J; Lu M; Gao X
Cancer Biomark; 2016; 16(3):351-8. PubMed ID: 26889981
[TBL] [Abstract][Full Text] [Related]
22. Benign prostate hyperplasia: average volume in southwestern Nigerians and correlation with anthropometrics.
Badmus TA; Asaleye CM; Badmus SA; Takure AO; Ibrahim MH; Arowolo OA
Niger Postgrad Med J; 2012 Mar; 19(1):15-8. PubMed ID: 22430596
[TBL] [Abstract][Full Text] [Related]
23. SPINK1 Promoter Variants Are Associated with Prostate Cancer Predisposing Alterations in Benign Prostatic Hyperplasia Patients.
Winchester D; Ricks-Santi L; Mason T; Abbas M; Copeland RL; Beyene D; Jingwi EY; Dunston GM; Kanaan YM
Anticancer Res; 2015 Jul; 35(7):3811-9. PubMed ID: 26124326
[TBL] [Abstract][Full Text] [Related]
24. Gene variations in sex hormone pathways and the risk of testicular germ cell tumour: a case-parent triad study in a Norwegian-Swedish population.
Kristiansen W; Andreassen KE; Karlsson R; Aschim EL; Bremnes RM; Dahl O; Fosså SD; Klepp O; Langberg CW; Solberg A; Tretli S; Adami HO; Wiklund F; Grotmol T; Haugen TB
Hum Reprod; 2012 May; 27(5):1525-35. PubMed ID: 22402210
[TBL] [Abstract][Full Text] [Related]
25. Single and multigenic analysis of the association between variants in 12 steroid hormone metabolism genes and risk of prostate cancer.
Beuten J; Gelfond JA; Franke JL; Weldon KS; Crandall AC; Johnson-Pais TL; Thompson IM; Leach RJ
Cancer Epidemiol Biomarkers Prev; 2009 Jun; 18(6):1869-80. PubMed ID: 19505920
[TBL] [Abstract][Full Text] [Related]
26. CYP17 polymorphisms in relation to risks of prostate cancer and benign prostatic hyperplasia: a population-based study in China.
Madigan MP; Gao YT; Deng J; Pfeiffer RM; Chang BL; Zheng S; Meyers DA; Stanczyk FZ; Xu J; Hsing AW
Int J Cancer; 2003 Nov; 107(2):271-5. PubMed ID: 12949806
[TBL] [Abstract][Full Text] [Related]
27. The epidemiology of sex steroid hormones and their signaling and metabolic pathways in the etiology of prostate cancer.
Platz EA; Giovannucci E
J Steroid Biochem Mol Biol; 2004 Nov; 92(4):237-53. PubMed ID: 15663987
[TBL] [Abstract][Full Text] [Related]
28. Phytoestrogen tissue levels in benign prostatic hyperplasia and prostate cancer and their association with prostatic diseases.
Brössner C; Petritsch K; Fink K; Auprich M; Madersbacher S; Adlercreutz H; Rehak P; Petritsch P
Urology; 2004 Oct; 64(4):707-11. PubMed ID: 15491706
[TBL] [Abstract][Full Text] [Related]
29. Bipolar plasma enucleation of the prostate vs open prostatectomy in large benign prostatic hyperplasia cases - a medium term, prospective, randomized comparison.
Geavlete B; Stanescu F; Iacoboaie C; Geavlete P
BJU Int; 2013 May; 111(5):793-803. PubMed ID: 23469933
[TBL] [Abstract][Full Text] [Related]
30. Impact of prostate-specific antigen level and prostate volume as predictors of efficacy in photoselective vaporization prostatectomy: analysis and results of an ongoing prospective multicentre study at 3 years.
Te AE; Malloy TR; Stein BS; Ulchaker JC; Nseyo UO; Hai MA
BJU Int; 2006 Jun; 97(6):1229-33. PubMed ID: 16686717
[TBL] [Abstract][Full Text] [Related]
31. Association of androgen receptor, prostate-specific antigen, and CYP19 gene polymorphisms with prostate carcinoma and benign prostatic hyperplasia in a north Indian population.
Soni A; Bansal A; Mishra AK; Batra J; Singh LC; Chakraborty A; Yadav DS; Mohanty NK; Saxena S
Genet Test Mol Biomarkers; 2012 Aug; 16(8):835-40. PubMed ID: 22731640
[TBL] [Abstract][Full Text] [Related]
32. Genetic interaction analysis of TCF7L2 for biochemical recurrence after radical prostatectomy in localized prostate cancer.
Chen CS; Huang CY; Huang SP; Lin VC; Yu CC; Chang TY; Bao BY
Int J Med Sci; 2015; 12(3):243-7. PubMed ID: 25678841
[TBL] [Abstract][Full Text] [Related]
33. Transurethral enucleation and resection of the prostate vs transvesical prostatectomy for prostate volumes >80 mL: a prospective randomized study.
Ou R; Deng X; Yang W; Wei X; Chen H; Xie K
BJU Int; 2013 Jul; 112(2):239-45. PubMed ID: 23795788
[TBL] [Abstract][Full Text] [Related]
34. [The quotient of prostate-specific antigen and prostate volume. Improved differentiation between benign prostatic hyperplasia and locally circumscribed prostate cancer].
Semjonow A; Hamm M; Rathert P
Urologe A; 1993 May; 32(3):250-3. PubMed ID: 7685557
[TBL] [Abstract][Full Text] [Related]
35. Comparative randomized study on the efficaciousness of treatment of BOO due to BPH in patients with prostate up to 100 gr by endoscopic gyrus prostate resection versus open prostatectomy. Preliminary data.
Giulianelli R; Brunori S; Gentile BC; Vincenti G; Nardoni S; Pisanti F; Shestani T; Mavilla L; Albanesi L; Attisani F; Mirabile G; Schettini M
Arch Ital Urol Androl; 2011 Jun; 83(2):88-94. PubMed ID: 21826881
[TBL] [Abstract][Full Text] [Related]
36. A retrospective study: correlation of histologic inflammation in biopsy specimens of Chinese men undergoing surgery for benign prostatic hyperplasia with serum prostate-specific antigen.
Song L; Zhu Y; Han P; Chen N; Lin D; Lai J; Wei Q
Urology; 2011 Mar; 77(3):688-92. PubMed ID: 20974483
[TBL] [Abstract][Full Text] [Related]
37. Immunogenetics of prostate cancer and benign hyperplasia--the potential use of an HLA-G variant as a tag SNP for prostate cancer risk.
Zambra FM; Biolchi V; de Cerqueira CC; Brum IS; Castelli EC; Chies JA
HLA; 2016 Feb; 87(2):79-88. PubMed ID: 26889902
[TBL] [Abstract][Full Text] [Related]
38. Plasmakinetic enucleation of the prostate versus transvesical open prostatectomy for benign prostatic hyperplasia >80 mL: 12-month follow-up results of a randomized clinical trial.
Rao JM; Yang JR; Ren YX; He J; Ding P; Yang JH
Urology; 2013 Jul; 82(1):176-81. PubMed ID: 23601443
[TBL] [Abstract][Full Text] [Related]
39. Association of LTβR gene polymorphisms with prostate volume in benign prostatic hyperplasia in the Korean population.
Lee SH; Kim SK; Yoo KH; Chung JH; Chang SG
Genet Mol Res; 2015 Dec; 14(4):18607-15. PubMed ID: 26782510
[TBL] [Abstract][Full Text] [Related]
40. Calculated fast-growing benign prostatic hyperplasia--a risk factor for developing clinical prostate cancer.
Hammarsten J; Högstedt B
Scand J Urol Nephrol; 2002; 36(5):330-8. PubMed ID: 12487736
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
